SRR1464451
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- KRAS_SIGNALING_DN+0.373
- HEDGEHOG_SIGNALING+0.307
- SPERMATOGENESIS+0.303
- PANCREAS_BETA_CELLS+0.272
- MYOGENESIS+0.193
- UV_RESPONSE_DN+0.184
- APICAL_JUNCTION+0.169
- APICAL_SURFACE+0.165
- REACTIVE_OXYGEN_SPECIES_PATHWAY+0.146
- OXIDATIVE_PHOSPHORYLATION+0.137
Top 10 suppressed
- IL6_JAK_STAT3_SIGNALING-0.537
- MYC_TARGETS_V1-0.493
- INTERFERON_ALPHA_RESPONSE-0.463
- E2F_TARGETS-0.462
- INTERFERON_GAMMA_RESPONSE-0.424
- G2M_CHECKPOINT-0.410
- PROTEIN_SECRETION-0.366
- INFLAMMATORY_RESPONSE-0.362
- CHOLESTEROL_HOMEOSTASIS-0.359
- TNFA_SIGNALING_VIA_NFKB-0.358
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1399028 | GTEX | — | 0.969 |
| 2 | SRR1480059 | GTEX | — | 0.968 |
| 3 | SRR1439807 | GTEX | — | 0.963 |
| 4 | SRR1466993 | GTEX | — | 0.962 |
| 5 | SRR1357523 | GTEX | — | 0.961 |
| 6 | SRR1490019 | GTEX | — | 0.960 |
| 7 | SRR1488672 | GTEX | — | 0.957 |
| 8 | SRR1324371 | GTEX | — | 0.957 |
| 9 | SRR1310008 | GTEX | — | 0.957 |
| 10 | SRR1474951 | GTEX | — | 0.957 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 12 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| KRAS_SIGNALING_DN | 0.373 | Remibrutinib | — uncovered |
| HEDGEHOG_SIGNALING | 0.307 | Inavolisib | — uncovered |
| SPERMATOGENESIS | 0.303 | Inavolisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.272 | Cobimetinib | — uncovered |
| MYOGENESIS | 0.193 | Inavolisib | — uncovered |
| UV_RESPONSE_DN | 0.184 | Inavolisib | — uncovered |
| APICAL_JUNCTION | 0.169 | Inavolisib | — uncovered |
| APICAL_SURFACE | 0.165 | Temsirolimus | — uncovered |
| REACTIVE_OXYGEN_SPECIES_PATHWAY | 0.146 | Inavolisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.137 | Remibrutinib | — uncovered |
| ESTROGEN_RESPONSE_EARLY | 0.120 | Inavolisib | — uncovered |
| ESTROGEN_RESPONSE_LATE | 0.088 | Idelalisib | — uncovered |